Preanalytical factors and reference intervals for serum hepcidin LC-MS/MS method

Clinica Chimica Acta

Volumn 413, Issue 7-8, 2012, Pages 696-701

  Itkonen, Outi ^a,b   Parkkinen, Jaakko ^a   Stenman, Ulf Håkan ^a,b   Hämäläinen, Esa ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Competitive ELISA; Hepcidin; LC MS MS; Preanalytical factors; Reference intervals

Indexed keywords

HEPCIDIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; ROOM TEMPERATURE; SEX DIFFERENCE; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; VALIDITY;

ANTIMICROBIAL CATIONIC PEPTIDES; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 84857656638     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.12.015     Document Type: Article

References (34)

1. Kroot J.J., Tjalsma H., Fleming R.E., Swinkels D.W. Hepcidin in Human Iron Disorders: Diagnostic Implications. Clin Chem 2011, 57:1650-1669.
2. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101:2461-2463.
3. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001, 276:7806-7810.
4. Nemeth E., Tuttle M.S., Powelson J., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
5. Franchini M., Montagnana M., Lippi G. Hepcidin and iron metabolism: from laboratory to clinical implications. Clin Chim Acta 2010, 411:1565-1569.
6. Tomosugi N., Kawabata H., Wakatabe R., et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 2006, 108:1381-1387.
7. Kemna E., Tjalsma H., Laarakkers C., Nemeth E., Willems H., Swinkels D. Novel urine hepcidin assay by mass spectrometry. Blood 2005, 106:3268-3270.
8. Kemna E.H., Tjalsma H., Podust V.N., Swinkels D.W. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 2007, 53:620-628.
9. Bansal S.S., Halket J.M., Fusova J., et al. Quantification of hepcidin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2009, 23:1531-1542.
10. Bozzini C., Campostrini N., Trombini P., et al. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis 2008, 40:347-352.
11. Swinkels D.W., Girelli D., Laarakkers C., et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 2008, 3:e2706.
12. Ward D.G., Roberts K., Stonelake P., et al. SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. Proteome Sci 2008, 6:28.
13. Anderson D.S., Heeney M.M., Roth U., Menzel C., Fleming M.D., Steen H. High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine. Anal Chem 2010, 82:1551-1555.
14. Kroot J.J., Laarakkers C.M., Geurts-Moespot A.J., et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010, 56:1570-1579.
15. Bansal S.S., Halket J.M., Bomford A., et al. Quantitation of hepcidin in human urine by liquid chromatography-mass spectrometry. Anal Biochem 2009, 384:245-253.
16. Murphy A.T., Witcher D.R., Luan P., Wroblewski V.J. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007, 110:1048-1054.
17. Murao N., Ishigai M., Yasuno H., Shimonaka Y., Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom 2007, 21:4033-4038.
18. Bansal S.S., Abbate V., Bomford A., et al. Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom 2010, 24:1251-1259.
19. Kobold U., Dulffer T., Dangl M., et al. Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry. Clin Chem 2008, 54:1584-1586.
20. Li H., Rose M.J., Tran L., et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009, 59:171-180.
21. Crockett D.K., Kushnir M.M., Phillips J.D., Rockwood A.L. Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25. Clin Chim Acta 2010, 411:453-455.
22. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M. Immunoassay for human serum hepcidin. Blood 2008, 112:4292-4297.
23. Busbridge M., Griffiths C., Ashby D., et al. Development of a novel immunoassay for the iron regulatory peptide hepcidin. Br J Biomed Sci 2009, 66:150-157.
24. Butterfield A.M., Luan P., Witcher D.R., et al. A dual-monoclonal sandwich ELISA specific for hepcidin-25. Clin Chem 2010, 56:1725-1732.
25. Koliaraki V., Marinou M., Vassilakopoulos T.P., et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One 2009, 4:e4581.
26. Grebenchtchikov N., Geurts-Moespot A.J., Kroot J.J., et al. High-sensitive radioimmunoassay for human serum hepcidin. Br J Haematol 2009, 146:317-325.
27. Ashby D.R., Gale D.P., Busbridge M., et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 2009, 75:976-981.
28. Kroot J.J., Kemna E.H., Bansal S.S., et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009, 94:1748-1752.
29. Felding P., Rustad P., Martensson A., et al. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004, 64:327-342.
30. Parkkinen J., Sahlstedt L., von Bonsdorff L., Salo H., Ebeling F., Ruutu T. Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol 2006, 135:228-234.
31. Lahti A., Hyltoft Petersen P., Boyd J.C., Fraser C.G., Jorgensen N. Objective criteria for partitioning Gaussian-distributed reference values into subgroups. Clin Chem 2002, 48:338-352.
32. Galesloot T.E., Vermeulen S.H., Geurts-Moespot A.J., et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011, 117:e218-e225.
33. Neurath H. Proteolytic enzymes, past and future. Proc Natl Acad Sci U S A 1999, 96:10962-10963.
34. Kroot J.J., Hendriks J.C., Laarakkers C.M., et al. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem 2009, 389:124-129.